Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
IsoPlexis
company
About
IsoPlexis is a life science technology company that develops a single-cell detection system identifying patient immune responses.
- Branford,Connecticut,United States
- 251 - 500
- http://isoplexis.com
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $300K
- Industries
- Biotechnology,Health Care,Medical Device,Therapeutics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 251 - 500
- Operating Status
- Active
- Stock Symbol
- nasdaq:ISO
- Legal Name
- IsoPlexis Corporation
IsoPlexis is a life science technology company developing a single-cell detection system that identifies a wide range of patient immune responses at the single-cell level. Its platform can assess the safety and efficacy of therapeutics and monitor disease progression, enabling improved therapeutic development, and informing physician decisions. The company was founded in 2013 and is headquartered in Branford, Connecticut.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
14
$455.40M
IsoPlexis has raised a total of
$455.40M
in funding over 2 rounds. Their latest funding was raised on
Oct 12, 2021 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 12, 2021 | Post-IPO Equity | $125M | — | — | — | Detail |
| Oct 8, 2021 | IPO | $125M | — | — | — | Detail |
| Jan 7, 2021 | Series D | $85M | 3 |
Perceptive Advisors
|
— | Detail |
| Jan 7, 2021 | Debt Financing | $50M | 3 |
Perceptive Advisors
|
— | Detail |
| Jun 9, 2020 | Grant | $2M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
9
13
IsoPlexis is funded by 13 investors.
Perceptive Advisors
and National Institute on Aging
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Perceptive Advisors
|
Yes | Series D |
|
|
Yes | Grant |
|
|
Yes | Series C |
National Cancer Institute SBIR Development Center
|
Yes | Grant |
|
|
— | Series D |
BlackRock
|
— | Series D |
Advantage Capital
|
— | Series C |
|
|
— | Series C |
Ironwood Capital
|
— | Series C |
North Sound Capital
|
— | Series C |
Employee Profiles
Number of Employee Profiles
9
IsoPlexis has 9 current employee profiles, including
Board member Gregory P. Ho
Board member
Board member
Executive
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
